iquid biopsies for CNS tumors

• Conditions: brain tumor; 10029211

• Registration Number: NL-OMON53668
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Radiological suspected brain tumor

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The ability to detect ctDNA in patients with brain tumors while using the<br /><br>Med-Seq technique<br /><br><br /><br>Determine whether T cell phenotype changes during the course of the disease of<br /><br>glioma</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>